Please list the factors that affect TEVA.TA stocks price. Company Performance: Revenue, earnings, and profitability significantly impact investor confidence and stock value. Strong financial results typically drive prices up, while poor performance can lead to declines. Pharmaceutical Pipeline: The success rate and potential revenue from new drugs in development influence investor sentiment. Positive clinical trial outcomes boost the stock, while failures can hurt it. Generic Drug Pricing: Changes in generic drug prices, affected by competition and regulations, directly impact Teva's revenue and profitability, influencing stock prices. Legal & Regulatory Issues: Lawsuits, patent challenges, and regulatory decisions (like FDA approvals or rejections) can drastically alter Teva's financial outlook and investor perception. Debt Levels: High debt burdens can worry investors, particularly if Teva struggles to service its debt. Debt restructuring or successful deleveraging can positively impact the stock. Market Conditions: General economic trends and the overall performance of the pharmaceutical industry influence investor sentiment and trading activity in TEVA.TA. Currency Fluctuations: As a global company, Teva's revenue is affected by currency exchange rates, especially the relative strength of the Israeli Shekel versus other currencies, impacting profitability and stock price. Competition: The intensity of competition from other generic and branded pharmaceutical companies affects market share and pricing power, thereby influencing Teva's financial performance and stock valuation.